6 Neoantigen Vaccine Breakthroughs Redefining Personalized Cancer Therapy in 2026
The National Comprehensive Cancer Network's 2026 updated clinical practice guidelines for melanoma and non-small cell lung cancer have for the first time included neoantigen vaccine therapy as a recommended option within the context of adjuvant immunotherapy for patients with high tumor mutational burden, marking the moment personalized cancer immunization crossed from experimental status into...
0 Comments 0 Shares 70 Views 0 Reviews